Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the effectiveness, safety and pharmacokinetics of Oral Nalbuphine in the treatment of postoperative pain following hemorrhoidectomy.


Clinical Trial Description

• Primary Efficacy Endpoint: Pain assessment calculated as the area under the curve of VAS pain intensity scores through 48 hours. • Secondary Efficacy Endpoints: 1. Consumption of diclofenac (Day 1-2) via Intramuscular Injection (IM injection). 2. Time from the end of operation to the first IM injection diclofenac dose 3. Brief Pain Inventory (BPI). 4. Patient satisfaction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02193620
Study type Interventional
Source PhytoHealth Corporation
Contact
Status Completed
Phase Phase 2/Phase 3
Start date April 30, 2013
Completion date February 13, 2019

See also
  Status Clinical Trial Phase
Terminated NCT02192151 - Study of PHN131 in Healthy Volunteers N/A
Recruiting NCT02195271 - Neuroplasticity:Melatonin and Transcranial Current Stimulation in Healthy Subjects. Phase 2
Completed NCT02122510 - Transverse Abdominal Block for Analgesia in Casarean Section N/A
Completed NCT02446301 - A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers Phase 1
Completed NCT03107585 - Intermediate Cervical Block Under Ultrasound for Thyroid Surgery: Impact on Per and Postoperative Opioid Consumption N/A
Completed NCT02315261 - Effectiveness of Epidural Anesthesia for Thoracic and Abdominal Surgery
Completed NCT02468128 - A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management Phase 2/Phase 3
Completed NCT01785823 - Fentanyl Background Infusion for Acute Postoperative Pain N/A